University Vita Salute

University Vita Salute becomes clinical research partner of Bulbitech AS

Article / News  University Vita Salute becomes clinical research partner of Bulbitech AS Bulbitech is pleased to announce that we have entered into a clinical research agreement with University Vita Salute – Ospedale San Raffaele in Milan, Italy. Effective from January 14th, 2022, the University of Vita Salute will validate functional vision tests, performed with […]

Prof. Dr. rer. nat. Michael Bach has decided to join our clinical advisory board

Bulbitech is excited to announce that Prof. Dr. rer. nat. Michael Bach has decided to join our clinical advisory board. Professor Bach is a German scientist who has done research into ophthalmology, clinical electroencephalography, clinical electroretinography, visual acuity testing, and visual perception. He also created a website, Optical Illusions & Visual Phenomena, that received over […]

Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikkeren

Article / News  Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikkeren Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikkeren, a magazine for Norwegian optometry & visual sciences. The article describes our clinical research with Oslo University Hospital, the University of South-East Norway and the collaboration with optician […]

A haploscope based binocular pupillometer system to quantify the dynamics of direct and consensual Pupillary Light Reflex

Article / News  A haploscope based binocular pupillometer system to quantify the dynamics of direct and consensual Pupillary Light Reflex Bulbitech’s technology is featured in the innovation section of Norwegian magazine Optikeren, a magazine for Norwegian optometry & visual sciences. The article describes our clinical research with Oslo University Hospital, the University of South-East Norway […]

2. BulbiCAM overview

2. BulbiCAM overview Overview of the BulbiCAM’s parts. Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn